Dr Patrick Cole, MD | |
1070 N Curtis Rd Ste 135, Boise, ID 83706-1257 | |
(208) 947-5390 | |
(208) 947-3465 |
Full Name | Dr Patrick Cole |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 20 Years |
Location | 1070 N Curtis Rd Ste 135, Boise, Idaho |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023337631 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0122X | Surgery - Plastic And Reconstructive Surgery | M14785 (Idaho) | Primary |
207XS0106X | Orthopaedic Surgery - Hand Surgery | M14785 (Idaho) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Alphonsus Regional Medical Center | Boise, ID | Hospital |
St Luke's Regional Medical Center | Boise, ID | Hospital |
Entity Name | Boise Plastic Surgery Boise Hand Center Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1699316190 PECOS PAC ID: 7012349723 Enrollment ID: O20191119001494 |
News Archive
New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline.
RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire five imaging centers in Northern New Jersey and a 50% equity interest in a sixth center from Progressive Health, LLC and certain affiliates and related entities.
Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.
Researchers from The Cancer Genome Atlas Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer.
A gene therapy approach to treating the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD) that does not replace the mutated DMD gene but instead delivers the gene for ITGA7, a protein in skeletal muscle, led to reduced symptoms and significantly extended life span in a mouse model of severe DMD. Over-expression of ITGA7 did not elicit an immune reaction, further supporting its potential as a novel treatment for DMD, according to a new study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Patrick Cole, MD Po Box 4655, Boise, ID 83711-4655 Ph: (928) 774-2300 | Dr Patrick Cole, MD 1070 N Curtis Rd Ste 135, Boise, ID 83706-1257 Ph: (208) 947-5390 |
News Archive
New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living with type 2 diabetes, ACTOS (pioglitazone HCl) reduced the atherosclerotic burden in the coronary arteries compared to glimepiride, and prevented progression compared to baseline.
RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today reported it has executed a definitive agreement to acquire five imaging centers in Northern New Jersey and a 50% equity interest in a sixth center from Progressive Health, LLC and certain affiliates and related entities.
Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.
Researchers from The Cancer Genome Atlas Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer.
A gene therapy approach to treating the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD) that does not replace the mutated DMD gene but instead delivers the gene for ITGA7, a protein in skeletal muscle, led to reduced symptoms and significantly extended life span in a mouse model of severe DMD. Over-expression of ITGA7 did not elicit an immune reaction, further supporting its potential as a novel treatment for DMD, according to a new study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 2 days ago
Dr. Craig B. Bass, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 250 Bobwhite Ct, # 275, Boise, ID 83706 Phone: 208-333-0200 Fax: 208-333-0399 | |
Aziz George Munayirji, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 999 N Curtis Rd, Suite 415, Boise, ID 83706 Phone: 208-367-7676 Fax: 208-367-5595 | |
John M Livingston, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 8756 W Emerald St, Suite 136, Boise, ID 83704 Phone: 208-853-3051 Fax: 208-853-3053 | |
Jason A Kemp, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 222 N 2nd St, Suite 202, Boise, ID 83702 Phone: 208-381-6390 Fax: 208-381-6395 | |
Dr. Graham W Donald, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 N 1st St Ste 280, Boise, ID 83702 Phone: 208-345-6545 Fax: 208-345-1213 | |
Courtney Alyson Green, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 999 N Curtis Rd Ste 415, Boise, ID 83706 Phone: 208-302-2600 Fax: 208-302-2625 |